A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
Trial details
- Registry ID
- NCT06872125
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet SyndromeNCT06872125 | STOK | Phase 3 | Active not recruiting | 2027-03Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |